Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Clin Pharmacol Ther. 2018 May 15;104(6):1175–1181. doi: 10.1002/cpt.1093

Figure 1.

Figure 1

Number of regulatory applications (INDs) with FDA- generated documents in the DARRTS database that referenced KIM-1 as a drug development tool from 2005–2016.